CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OCProDx project has developed a blood test that helps men with prostate cancer make informed decisions about treatment or active surveillance. This patented test distinguishes between localized and advanced disease, aiming to reduce unnecessary treatments and improve patients' quality of life.
In Europe over 400,000 (US >250,000, globally >1M) men are diagnosed with prostate cancer every year and well over half will have intermediate to low risk disease.
The vast majority of these men would benefit from active surveillance (AS) - monitoring of disease progression before treatment.
But most are treated by surgery, radiation or drugs because existing diagnostic tools do not adequately support the AS vs. treatment decision.
For those men on AS the tests do easily allow long term repeated…
ATTUROS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
